WallStreetZenWallStreetZen

NASDAQ: PAVM
Pavmed Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PAVM

Based on 1 analyst offering 12 month price targets for Pavmed Inc

Min Forecast
$65.00+662.02%
Avg Forecast
$65.00+662.02%
Max Forecast
$65.00+662.02%

Should I buy or sell PAVM stock?

Based on 1 analyst offering ratings for Pavmed Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PAVM stock forecasts and price targets.

PAVM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-09

1 of 1

Forecast return on equity

Is PAVM forecast to generate an efficient return?

Company
-33.54%
Industry
20.35%
Market
136.42%
PAVM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PAVM forecast to generate an efficient return on assets?

Company
-29.36%
Industry
10.82%
PAVM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PAVM earnings per share forecast

What is PAVM's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$2.74
Avg 2 year Forecast
-$1.79

PAVM revenue forecast

What is PAVM's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$499.8k+603.94%
Avg 2 year Forecast
$665.6k+837.39%
PAVM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PAVM revenue growth forecast

How is PAVM forecast to perform vs Medical Devices companies and vs the US market?

Company
603.94%
Industry
9.59%
Market
171.4%
PAVM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PAVM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PAVM vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
PAVM$8.53$65.00+662.02%Buy
NSPR$1.15N/AN/A
ECOR$6.64$18.00+171.08%Buy
ARAY$0.47$2.00+328.27%Strong Buy
COCH$0.68$2.50+267.11%Buy
View Top Medical Device Stocks

Pavmed Stock Forecast FAQ

Is Pavmed Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: PAVM) stock is to Buy PAVM stock.

Out of 1 analyst, 0 (0%) are recommending PAVM as a Strong Buy, 1 (100%) are recommending PAVM as a Buy, 0 (0%) are recommending PAVM as a Hold, 0 (0%) are recommending PAVM as a Sell, and 0 (0%) are recommending PAVM as a Strong Sell.

If you're new to stock investing, here's how to buy Pavmed stock.

What is PAVM's earnings growth forecast for 2026-2027?

(NASDAQ: PAVM) Pavmed's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 52.41%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,431.06%.

Pavmed's earnings in 2026 is -$3,774,000.On average, 4 Wall Street analysts forecast PAVM's earnings for 2026 to be -$17,513,920, with the lowest PAVM earnings forecast at -$16,827,099, and the highest PAVM earnings forecast at -$18,029,035.

In 2027, PAVM is forecast to generate -$11,393,814 in earnings, with the lowest earnings forecast at -$10,946,998 and the highest earnings forecast at -$11,728,926.

What is PAVM's revenue growth forecast for 2026-2027?

(NASDAQ: PAVM) Pavmed's forecast annual revenue growth rate of 603.94% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.59%, and it is also forecast to beat the US market's average forecast revenue growth rate of 171.4%.

Pavmed's revenue in 2026 is $71,000.On average, 4 Wall Street analysts forecast PAVM's revenue for 2026 to be $3,190,268, with the lowest PAVM revenue forecast at $3,002,605, and the highest PAVM revenue forecast at $3,351,122.

In 2027, PAVM is forecast to generate $4,248,265 in revenue, with the lowest revenue forecast at $3,127,714 and the highest revenue forecast at $5,395,306.

What is PAVM's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: PAVM) forecast ROA is -29.36%, which is lower than the forecast US Medical Devices industry average of 10.82%.

What is PAVM's Price Target?

According to 1 Wall Street analyst that have issued a 1 year PAVM price target, the average PAVM price target is $65.00, with the highest PAVM stock price forecast at $65.00 and the lowest PAVM stock price forecast at $65.00.

The Wall Street analyst predicted that Pavmed's share price could reach $65.00 by Apr 9, 2027. The average Pavmed stock price prediction forecasts a potential upside of 662.02% from the current PAVM share price of $8.53.

What is PAVM's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: PAVM) Pavmed's current Earnings Per Share (EPS) is -$5.63. On average, analysts forecast that PAVM's EPS will be -$2.74 for 2026, with the lowest EPS forecast at -$2.64, and the highest EPS forecast at -$2.82. In 2027, PAVM's EPS is forecast to hit -$1.79 (min: -$1.72, max: -$1.84).

What is PAVM's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: PAVM) forecast ROE is -33.54%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.